Sunshine Heart, a global company that develops cardiac assist devices, has successfully completed the first two implants of the company’s C-Pulse heart assist system under a 20-person clinical trial approved by the U.S. Food and Drug Administration.
Symphony Medical, a developer of novel biopolymer technologies for cardiac disorders, has successfully used its flagship Algisyl-LVR technology to treat their first human patient.
The idea of putting electrodes on one’s eyelids might cause many to cringe, but ScyFIX of Minnesota is turning this odd concept into a promising treatment for age-related vision loss.
Join medical technology company investors and acquirers and secure your spot at the Leading Medical Device Strategic Partnering and Investment Event in Paris, France. Don’t […]
Some patients fear injections so much that they avoid getting proper medical treatment, sometimes with life-threatening results. Transdermal patches, which administer drugs through the skin, could make the bite of the needle a mere unpleasant memory.
The collaboration of two pharmaceutical giants may mark the beginning of an industry shift. Pfizer and GlaxoSmithKline are combining their HIV drug businesses into a single, jointly owned company that will account for almost 20 percent of the market.
Embryonic stem-cell research would get a financial boost under a new proposal by the National Institutes of Health. According to the Wall Street Journal, the NIH guidelines expand funding for cell lines derived from surplus human embryos.
According to the National Kidney Foundation, over 26 million Americans suffer from chronic kidney disease (CKD), a progressive condition in which the kidneys allow waste to build up in the blood.
President Obama’s recent reversal of Bush’s policy on embryonic stem cell research reignited the debate over the ethical limits of science. However, as the Wall Street Journal reports, an innovative new technique could potentially reproduce the benefits of embryonic stem cells without the attendant controversy.
Foundation Radiology Group, a provider of diagnostic imaging services to hospitals and medical institutions, announced that it has raised $10 million in the company’s first round of venture funding.
Copyright © 2024 | WordPress Theme by MH Themes